Additional Metadata
Keywords Adalimumab, Methotrexate, Noninferiority, Placebo, Psoriasis, Randomized controlled trial
Persistent URL dx.doi.org/10.1111/j.1365-2133.2008.08606.x, hdl.handle.net/1765/29169
Journal British Journal of Dermatology
Citation
Nijsten, T.E.C, & Spuls, P.I. (2008). Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis. British Journal of Dermatology, 159(1), 257–258. doi:10.1111/j.1365-2133.2008.08606.x